AstraZeneca PLC Ordinary Shares (AZN)
Cost of Revenue
$2.52B
Quarterly · Period ending: · USD
AZN Cost of Revenue
Latest reported$2.52Bperiod ending
Latest reported$2.52Bperiod ending
AZN Quarterly Cost of Revenue ($0.00 → $2.52B)
Quarterly cost of revenue
High-resolution chart · PNG
AZN cost of revenue history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Cost of Revenue (USD) |
|---|---|
| 1,112,000,000 | |
| 1,070,519,704 | |
| 0 | |
| 955,162,839 | |
| 1,013,651,281 | |
| 1,070,618,848 | |
| 0 | |
| 1,253,000,000 | |
| 1,207,500,000 | |
| 0 | |
| 0 | |
| 0 | |
| 825,500,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 947,900,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |